214 related articles for article (PubMed ID: 33625512)
1. Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.
Sun L; Parikh RB; Hubbard RA; Cashy J; Takvorian SU; Vaughn DJ; Robinson KW; Narayan V; Ky B
JAMA Netw Open; 2021 Feb; 4(2):e210070. PubMed ID: 33625512
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
3. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH
JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269
[TBL] [Abstract][Full Text] [Related]
4. Androgen Deprivation Therapy and Outcomes After Radiation Therapy in Black Patients With Prostate Cancer.
Morgan KM; Riviere P; Nelson TJ; Guram K; Deshler LN; Sabater Minarim D; Duran EA; Banegas MP; Rose BS
JAMA Netw Open; 2024 Jun; 7(6):e2415911. PubMed ID: 38857047
[TBL] [Abstract][Full Text] [Related]
5. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
6. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
Saydah SH; Gregg EW; Kahn HS; Ali MK
Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.
Schroeder EB; Hanratty R; Beaty BL; Bayliss EA; Havranek EP; Steiner JF
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):645-53. PubMed ID: 22851534
[TBL] [Abstract][Full Text] [Related]
8. Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.
Sussman JB; Kerr EA; Saini SD; Holleman RG; Klamerus ML; Min LC; Vijan S; Hofer TP
JAMA Intern Med; 2015 Dec; 175(12):1942-9. PubMed ID: 26502220
[TBL] [Abstract][Full Text] [Related]
9. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
[TBL] [Abstract][Full Text] [Related]
10. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer.
Jayadevappa R; Chhatre S; Malkowicz SB; Parikh RB; Guzzo T; Wein AJ
JAMA Netw Open; 2019 Jul; 2(7):e196562. PubMed ID: 31268539
[TBL] [Abstract][Full Text] [Related]
11. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Schmidt AL; Tucker MD; Bakouny Z; Labaki C; Hsu CY; Shyr Y; Armstrong AJ; Beer TM; Bijjula RR; Bilen MA; Connell CF; Dawsey SJ; Faller B; Gao X; Gartrell BA; Gill D; Gulati S; Halabi S; Hwang C; Joshi M; Khaki AR; Menon H; Morris MJ; Puc M; Russell KB; Shah NJ; Sharifi N; Shaya J; Schweizer MT; Steinharter J; Wulff-Burchfield EM; Xu W; Zhu J; Mishra S; Grivas P; Rini BI; Warner JL; Zhang T; Choueiri TK; Gupta S; McKay RR
JAMA Netw Open; 2021 Nov; 4(11):e2134330. PubMed ID: 34767021
[TBL] [Abstract][Full Text] [Related]
12. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
Omboni S; Carabelli G; Ghirardi E; Carugo S
Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
Basaria S; Muller DC; Carducci MA; Egan J; Dobs AS
Cancer; 2006 Feb; 106(3):581-8. PubMed ID: 16388523
[TBL] [Abstract][Full Text] [Related]
14. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
15. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.
Rehman H; Akeroyd JM; Ramsey D; Ahmed ST; Merchant AT; Navaneethan SD; Petersen LA; Virani SS
Clin Cardiol; 2017 Nov; 40(11):1055-1060. PubMed ID: 28841246
[TBL] [Abstract][Full Text] [Related]
16. Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
Keating NL; O'Malley AJ; Freedland SJ; Smith MR
Eur Urol; 2013 Jul; 64(1):159-66. PubMed ID: 22537796
[TBL] [Abstract][Full Text] [Related]
17. Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone.
Shiota M; Narita S; Akamatsu S; Fujimoto N; Sumiyoshi T; Fujiwara M; Uchiumi T; Habuchi T; Ogawa O; Eto M
JAMA Netw Open; 2019 Feb; 2(2):e190115. PubMed ID: 30794306
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
[TBL] [Abstract][Full Text] [Related]
19. Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
Harshman LC; Wang X; Nakabayashi M; Xie W; Valenca L; Werner L; Yu Y; Kantoff AM; Sweeney CJ; Mucci LA; Pomerantz M; Lee GS; Kantoff PW
JAMA Oncol; 2015 Jul; 1(4):495-504. PubMed ID: 26181260
[TBL] [Abstract][Full Text] [Related]
20. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer.
Derweesh IH; Diblasio CJ; Kincade MC; Malcolm JB; Lamar KD; Patterson AL; Kitabchi AE; Wake RW
BJU Int; 2007 Nov; 100(5):1060-5. PubMed ID: 17868420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
